Drug intelligence / Profile preview

Gubiao Jiedu Ling

Development stage
Unknown
Lead developer
Wuhan No.1 Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

Gubiao Jiedu Ling is a Traditional Chinese Medicine (TCM) formula developed by the Wuhan Hospital of Integrated Traditional Chinese and Western Medicine (also known as Wuhan No. 1 Hospital) for the prevention and treatment of COVID-19. Formulated during the early stages of the pandemic in Wuhan, it is classified as a hospital-made preparation (院内制剂). The formula is designed to strengthen the body's defensive exterior (Gubiao) and clear heat and toxins (Jiedu), aligning with TCM principles for managing viral respiratory infections. It was primarily administered to high-risk medical staff for prevention and to patients with mild COVID-19 symptoms to prevent disease progression. The preparation typically consists of a blend of herbs such as Astragalus membranaceus, Atractylodes macrocephala, and Saposhnikovia divaricata (the Yu Ping Feng San base) combined with heat-clearing herbs like Lonicera japonica and Forsythia suspensa.

Other names
固表解毒灵Gubiao Jiedu Ling Granules

Beyond the preview

Go deeper on Gubiao Jiedu Ling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gubiao Jiedu Ling.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call